共 50 条
- [43] Low immunogenic potential of tocilizumab in patients with rheumatoid arthritis: Analysis of four phase 3 clinical trials ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S534 - S534
- [45] Issues in the design of new clinical trials for rheumatoid arthritis therapeutics NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (12): : 641 - 648
- [46] Malignancies in rheumatoid arthritis (RA) clinical trials with adalimumab (HUMIRATM). ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S700 - S700
- [47] Issues in the design of new clinical trials for rheumatoid arthritis therapeutics Nature Clinical Practice Rheumatology, 2008, 4 : 641 - 648